Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Study shows one in ten young cancer patients develop metastatic recurrence

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence - a condition associated with significantly worse survival outcomes.

26 Nov 2025

New Cochrane reviews confirm the effectiveness of HPV vaccines in preventing cervical cancer

Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.

24 Nov 2025

Global collaboration accelerates progress toward eliminating cervical cancer

Cervical cancer will be the first human cancer eliminated through coordinated global action. A new special issue of Cancer Biology & Medicine brings together leading experts from around the world to examine progress, challenges, and innovations in prevention, screening, and treatment.

21 Nov 2025

Global action takes center stage on the first World Cervical Cancer Elimination Day

Today marks the first World Cervical Cancer Elimination Day – mandated by the World Health Assembly – a historic milestone in global efforts to end a preventable cancer.

17 Nov 2025

Patient preferences impact physician earnings in Canada

Physician responses to patient expectations can affect physician incomes and may help explain lower incomes for many women, racialized, and immigrant physicians, found a new study published in CMAJ.

17 Nov 2025

Enhancing the cancer-immunity cycle through innovative vaccines

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat malignancies.

14 Nov 2025

Nasal vaccine shows promise as a non-invasive treatment for cervical cancer

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide.

12 Nov 2025

Researchers achieve long-term remission with novel T cell therapies for HPV-related cancers

Researchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI) - designated Comprehensive Cancer Center, and RWJBarnabas Health, along with colleagues from the National Cancer Institute, a center of the National Institutes of Health, announced findings from two HPV-related studies that highlight the potential of novel T cell therapies to achieve long-lasting remission and complete tumor regression in patients with advanced epithelial cancers.

10 Nov 2025

Protein linked to cancer plays key role in wound healing

When doctors detect elevated levels of SerpinB3 in a blood test, it can signal that something is seriously wrong, from hard-to-treat cancers to severe inflammatory conditions.

7 Nov 2025

Single-cell analysis reveals HPV-induced keratinocyte heterogeneity in cervical cancer

Cervical squamous cell carcinoma (CESC), the most prevalent subtype of cervical cancer, remains a major global health burden driven primarily by persistent high-risk HPV infection and genetic susceptibility.

7 Nov 2025

Longer distance between family physicians and patients can be potential barrier to receiving care

Living farther than 30 km from a family physician can negatively affect access to health care, found a new Ontario study published in CMAJ.

3 Nov 2025

Lactate and lactylation drive metabolic, epigenetic reprogramming in gynecological cancers

Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression.

31 Oct 2025

Cervical cancer patients treated with radiation and chemotherapy report greater short-term decline in quality of life

A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that women with early-stage cervical cancer who received radiation plus chemotherapy reported a greater short-term decline in quality of life compared to those who received radiation alone.

23 Oct 2025

Intelligent learning can accelerate global efforts to prevent cervical cancer

Cervical cancer, one of the most preventable yet lethal malignancies among women, continues to threaten lives globally due to unequal access to quality screening and diagnosis.

22 Oct 2025

Bridging innovation and equity to end cervical cancer worldwide

Each year, more than 340,000 women die from cervical cancer, with the majority of deaths occurring in low- and middle-income countries.

13 Oct 2025

AI brings hope for cervical cancer detection in rural Africa

AI can be used to detect cervical cancer in women in resource-limited parts of the world. However, for this method to work, investments are needed in healthcare staff, reliable supply chains and trust in these communities.

10 Oct 2025

PAHO concludes 62nd Directing Council with Strategic Plan 2026-2031 for healthier Americas

The 62nd Directing Council of the Pan American Health Organization (PAHO) concluded today, setting a bold agenda to address pressing health challenges across the Americas through the approval of the PAHO Strategic Plan 2026-2031 and key resolutions aimed at expanding access to high-cost high price health technologies, and preventing and controlling noncommunicable diseases (NCDs).

6 Oct 2025

PAHO introduces new tool to accelerate disease elimination in the Americas

During a briefing session at the 62nd Directing Council of the Pan American Health Organization (PAHO), officials presented a new technical tool to help countries in the Region of the Americas accelerate the elimination of more than 30 communicable diseases and related conditions.

6 Oct 2025

Health authorities approve new plan to tackle NCDs in the Americas

Health authorities from across the Americas today approved a new 2025-2030 Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) during the 62nd Directing Council of the Pan American Health Organization (PAHO).

6 Oct 2025

New research reveals the cervix as a truly immunocompetent tissue

Cervical epithelial cells are far from passive bystanders in the body's immune system. New research shows they actually play an active and highly coordinated role in detecting and fighting infections. That's the conclusion of an international research team led by Associate Professor Cindrilla Chumduri from Aarhus University, and now published in the journal Science Advances.

6 Oct 2025

Cervical Cancer News and Research

Further Reading

Study shows one in ten young cancer patients develop metastatic recurrence

New Cochrane reviews confirm the effectiveness of HPV vaccines in preventing cervical cancer

Global collaboration accelerates progress toward eliminating cervical cancer

Global action takes center stage on the first World Cervical Cancer Elimination Day

Patient preferences impact physician earnings in Canada

Enhancing the cancer-immunity cycle through innovative vaccines

Nasal vaccine shows promise as a non-invasive treatment for cervical cancer

Researchers achieve long-term remission with novel T cell therapies for HPV-related cancers

Protein linked to cancer plays key role in wound healing

Single-cell analysis reveals HPV-induced keratinocyte heterogeneity in cervical cancer

Longer distance between family physicians and patients can be potential barrier to receiving care

Lactate and lactylation drive metabolic, epigenetic reprogramming in gynecological cancers

Cervical cancer patients treated with radiation and chemotherapy report greater short-term decline in quality of life

Intelligent learning can accelerate global efforts to prevent cervical cancer

Bridging innovation and equity to end cervical cancer worldwide

AI brings hope for cervical cancer detection in rural Africa

PAHO concludes 62nd Directing Council with Strategic Plan 2026-2031 for healthier Americas

PAHO introduces new tool to accelerate disease elimination in the Americas

Health authorities approve new plan to tackle NCDs in the Americas

New research reveals the cervix as a truly immunocompetent tissue

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News